Genus plc (GENSF)

Market Cap	2.28B
Revenue (ttm)	921.77M
Net Income (ttm)	26.44M
Shares Out	n/a
EPS (ttm)	0.40
PE Ratio	86.18
Forward PE	31.12
Dividend	0.41 (1.17%)
Ex-Dividend Date	Mar 6, 2025

Volume	100
Average Volume	5
Open	26.01
Previous Close	35.15
Day's Range	26.01 - 35.15
52-Week Range	20.51 - 35.15
Beta	0.58
RSI	98.94
Earnings Date	Sep 4, 2025

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. Further, ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1994
• Employees: 3,500
• Stock Exchange: OTCMKTS
• Ticker Symbol: GENSF

Financial Performance

In 2025, Genus's revenue was 672.80 million, an increase of 0.60% compared to the previous year's 668.80 million. Earnings were 19.30 million, an increase of 144.30%.

Financial numbers in GBP